Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,262 | 48,087 | 50,799 | 50,362 | 31,220 |
| Receivables | 866 | 251 | 136 | 112 | 90 |
| TOTAL | $44,904 | $51,593 | $55,439 | $53,356 | $33,736 |
| Non-Current Assets | |||||
| PPE Net | 976 | 1,000 | 870 | 825 | 609 |
| TOTAL | $976 | $1,000 | $870 | $825 | $609 |
| Total Assets | $45,880 | $52,593 | $56,309 | $54,180 | $34,346 |
| Liabilities | |||||
| Current Liabilities | |||||
| Other current liabilities | 408 | 106 | 154 | 238 | 655 |
| TOTAL | $2,690 | $2,709 | $2,582 | $2,409 | $2,709 |
| Non-Current Liabilities | |||||
| TOTAL | $7,091 | $7,172 | $7,241 | $7,102 | $6,883 |
| Total Liabilities | $9,781 | $9,881 | $9,823 | $9,511 | $9,593 |
| Shareholders' Equity | |||||
| Common Shares | 391,348 | 391,167 | 391,125 | 382,963 | 356,824 |
| Retained earnings | -393,416 | -385,664 | -380,792 | -373,546 | -367,111 |
| Other shareholders' equity | 4,005 | 4,024 | 3,929 | 3,977 | 4,018 |
| TOTAL | $36,099 | $42,712 | $46,487 | $44,670 | $24,753 |
| Total Liabilities And Equity | $45,880 | $52,593 | $56,309 | $54,180 | $34,346 |